us fda’s experience with medicines …...us fda’s experience with medicines communication using...
TRANSCRIPT
![Page 1: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/1.jpg)
US FDA’s Experience with Medicines Communication using Social Media
EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting
Workshop on social media
FDA, CDER Office of Communications, Division of Drug Information
CAPT Catherine Chew, PharmD Deputy Director, Division of Drug Information
Kimberly Chiu, PharmD CDER Social Media Lead, Division of Drug Information
![Page 2: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/2.jpg)
2
CDER/Office of Communications Center for Drug Evaluation and Research
Office of Communications
Division of Health Communications
Division of Drug Information
Division of Online Communications
![Page 3: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/3.jpg)
3
Know Your Audience Who is your target audience?
Patients and Consumers
Health Care Providers
Regulated Industry
![Page 4: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/4.jpg)
4
Know Your Audience What platform(s) does your target audience use?
FDA’s Center for Drug Evaluation and Research
![Page 5: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/5.jpg)
5
Know Your Audience What platform(s) does your target audience use?
FDA proactively segments twitter audiences
By Product Area (Examples)
Drugs: @FDA_Drug_Info
Biologics: @FDACBER
Tobacco: @FDATobacco
By Audience (Examples)
Patients: @FDA_Patient_Net
Press: @FDAMedia
Devices Industry: @FDACDRHIndustry
Spanish Speakers: @FDA_EnEspanol
By Programs (Examples)
openFDA: @openFDA
PrecisionFDA: @precisionFDA
![Page 6: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/6.jpg)
6
![Page 7: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/7.jpg)
7
Know Your Audience What are target audience(s) saying?
– Current concerns or questions – Current misperceptions or incorrect information – Current sentiment
Mentions to FDA
Mentions about FDA
General Mentions
![Page 8: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/8.jpg)
8
Know Your Tools Best practices
– Graphics and videos increase reach – Best time and how often – Remember mobile devices
![Page 9: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/9.jpg)
9
Know Your Tools • Identify natural partners
– Stakeholder organizations on social media – Medical information resource companies
![Page 10: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/10.jpg)
10
Know Your Tools Use metrics to optimize SM platforms
![Page 11: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/11.jpg)
11
Know Your Tools Use metrics to optimize SM platforms
![Page 12: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/12.jpg)
12
Know Your Challenges • As a Regulatory Agency:
– Must be neutral – Humanize FDA- “Operation Nice FDA”
• Other Rules, Regulations or Policies
![Page 13: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/13.jpg)
13
Know Your Challenges FDA’s Office of Prescription Drug Promotion Draft Guidance: Internet/Social Media Platforms with Character Space Limitations- Presenting Risk & Benefit Information for Prescription Drugs and Medical Devices
![Page 14: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/14.jpg)
14
Know Your Challenges
![Page 15: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/15.jpg)
15
Know Your Challenges
![Page 16: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/16.jpg)
16
Know Your Challenges
![Page 17: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/17.jpg)
17
Know Your Challenges
![Page 18: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/18.jpg)
18
Know Your Challenges Other Rules, Regulations or Policies • Commercial Confidential Information • Paperwork Reduction Act • 508 Compliance • Term of Service (TOS) Agreements
![Page 19: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/19.jpg)
Social Media as a part of communications strategy
![Page 20: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/20.jpg)
20
Fluoroquinolones
![Page 21: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/21.jpg)
21
Social Media Outreach
![Page 22: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/22.jpg)
22
Listen and Answer
![Page 23: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/23.jpg)
23
Listen and Answer on Social Media
I experienced an adverse event due to a fluoroquinolone.
How will doctors learn this information?
FDA needs to take more action.
![Page 24: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/24.jpg)
24
Listen on Stakeholder/Patient Sites
![Page 25: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/25.jpg)
25
Duchenne Muscular Dystrophy (DMD)
![Page 26: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/26.jpg)
26
![Page 27: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/27.jpg)
27
![Page 28: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and](https://reader036.vdocument.in/reader036/viewer/2022070722/5f01e0777e708231d4017856/html5/thumbnails/28.jpg)
28
(855) 543-3784 or (301) 796-3400 [email protected]
@FDA_DRUG_INFO www.facebook.com/fda
Questions? Comments?